Haemonetics Corp.

NYSE: HAE
Share price (4/22/24): $83.62
Market cap (4/22/24): $4.247 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

16 Haemonetics Corp. Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 12/30/23 Q3

ended 09/30/23 Q2

ended 07/01/23 Q1

ended 04/01/23 FY 2023

ended 12/31/22 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Updated info for already-effective prospectus

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Lingamneni Anila

Simon, Christopher

Neuberger Berman Group LLC

Vanguard Group Inc

Capital Research Global Investors

News Filter

Completes Acquisition of Attune Medical

Announces Definitive Agreement to Acquire Attune Medical

Reports Third Quarter and Year-To-Date Fiscal 2024 Results; Updates Fiscal 2024 Guidance

Completes Acquisition of OpSens Inc

Reports Second Quarter and First Half Fiscal 2024 Results; Updates Fiscal 2024 Guidance

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Conflict Minerals disclosure

Conflict Minerals disclosure

Conflict Minerals disclosure

Conflict Minerals disclosure